0.5750
0.0000
(0.00%)
As of March 7 at 9:59:01 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | 4.5M | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 13.5M | -- |
| Year Ago Sales | -- | -- | -- | 4.5M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -100.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 3ZO.F | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/19/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/12/2024 |
Related Tickers
CYTOF Altamira Therapeutics Ltd.
0.0700
0.00%
ALA.AX Arovella Therapeutics Limited
0.0770
-1.28%
DYAI Dyadic International, Inc.
1.2752
-4.84%
FBIOP Fortress Biotech, Inc.
5.30
-6.85%
LSB LakeShore Biopharma Co., Ltd
2.1100
-6.22%
RADX Radiopharm Theranostics Limited
4.5200
-5.83%
BRNS Barinthus Biotherapeutics plc
0.7200
-6.49%
IMU.AX Imugene Limited
0.0260
-7.14%
ACTU Actuate Therapeutics, Inc. Common stock
6.74
-6.50%
QNCX Quince Therapeutics, Inc.
1.2500
-0.79%